SEC Form 4 · accession 0001572426-15-000110
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George W Gunn
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 12:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Sep 9, 2015 | P | 4,236 | $5.031 | A | 5,636 | D | |
| Ordinary SharesF2 | Sep 9, 2015 | P | 5,764 | $5.835 | A | 11,400 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $5.355, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F2Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $6.00, inclusive.